Alleviation of calcium hydroxide nanoparticles induced genotoxicity and gastritis by coadministration of calcium titanate and yttrium oxide nanoparticles in mice.

Diverse applications of nanoparticles due to their unique properties has rapidly increased human exposure to numerous nanoparticles such as calcium hydroxide (Ca(OH) ₂ ), calcium titanate (CaTiO ₃ ), and yttrium oxide (Y ₂ O ₃ ) nanoparticles almost in all aspect of daily life. However, very limited data are available on the effect of these nanoparticles on genomic DNA integrity and inflammation induction in the gastric tissues. Hence, this study estimated the effect of Ca(OH) ₂ , CaTiO _3, or/and Y ₂ O ₃ nanoparticles multiple oral administration on the genomic DNA damage and inflammation induction in the mice gastric tissues. A suspension containing 50 mg/kg b.w of Ca(OH) ₂ , CaTiO _3, or Y ₂ O ₃ nanoparticles were given orally to male mice separately or together simultaneously three times a week for two consecutive weeks. Multiple oral administration of Ca(OH) ₂ nanoparticles led to significant elevations in DNA damage induction and ROS generation, in contrast to the non-significant changes observed in the level of induced DNA damage and generated ROS after administration of CaTiO ₃ or Y ₂ O ₃ nanoparticles separately or in combination with Ca(OH) ₂ nanoparticles. Oral administration of Ca(OH) ₂ nanoparticles alone also highly upregulated INOS and COX-2 genes expression and extremely decreased eNOS gene expression. However, high elevations in eNOS gene expression were detected after multiple administration of CaTiO ₃ and Y ₂ O ₃ nanoparticles separately or together simultaneously with Ca(OH) ₂ nanoparticles. Meanwhile, non-remarkable changes were noticed in the expression level of INOS and COX-2 genes after administration of CaTiO ₃ and Y ₂ O ₃ nanoparticles separately or simultaneously together with Ca(OH) ₂ nanoparticles. In conclusion: genomic DNA damage and inflammation induced by administration of Ca(OH) ₂ nanoparticles alone at a dose of 50 mg/kg were mitigated by about 100% when CaTiO ₃ and Y ₂ O ₃ nanoparticles were coadministered with Ca(OH) ₂ nanoparticles until they reached the negative control level through altering the expression level of eNOS, INOS and COX-2 genes and scavenging gastric ROS. Therefore, further studies are recommended to investigate the toxicological properties of Ca(OH) ₂ , CaTiO ₃ and Y ₂ O ₃ nanoparticles and possibility of using CaTiO ₃ and Y ₂ O ₃ nanoparticles to mitigate genotoxicity and inflammation induction by Ca(OH) ₂ nanoparticles.
(© 2023. The Author(s).)